<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>Thrombosis Awareness Library</title><link>https://www.spreaker.com/podcast/thrombosis-awareness-library--6780944</link><description><![CDATA[Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!]]></description><atom:link href="https://www.spreaker.com/show/6780944/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Medicine</category><copyright>Copyright Werfen EEMEA</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg</url><title>Thrombosis Awareness Library</title><link>https://www.spreaker.com/podcast/thrombosis-awareness-library--6780944</link></image><lastBuildDate>Fri, 28 Aug 2026 09:45:49 +0000</lastBuildDate><itunes:author>EEMEA</itunes:author><itunes:owner><itunes:name>Werfen</itunes:name><itunes:email>eemea@werfen.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:subtitle>Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. ...</itunes:subtitle><itunes:summary><![CDATA[Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!]]></itunes:summary><itunes:category text="Health &amp; Fitness"><itunes:category text="Medicine"/></itunes:category><itunes:explicit>false</itunes:explicit><podcast:guid>719b2d79-2477-58a9-8746-b700ed767fe1</podcast:guid><podcast:txt purpose="ai-content">true</podcast:txt><itunes:type>episodic</itunes:type><item><title>Epi 24 - Sepsis and Thrombosis</title><link>https://www.spreaker.com/episode/epi-24-sepsis-and-thrombosis--73428030</link><description><![CDATA[In patients with sepsis, coagulation pathways are frequently activated, promoting a prothrombotic state that may contribute to clot development and worsen disease severity and clinical outcomes. Coagulation abnormalities can range from mild thrombocytopenia and subtle clotting disturbances to severe disseminated intravascular coagulation.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/73428030</guid><pubDate>Tue, 08 Sep 2026 09:35:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/73428030/epi_24_sepsis_and_thrombosis.mp3" length="4613495" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/5874e9c3-6b01-46bd-ad8e-ae947dc63385/5874e9c3-6b01-46bd-ad8e-ae947dc63385.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/5874e9c3-6b01-46bd-ad8e-ae947dc63385/5874e9c3-6b01-46bd-ad8e-ae947dc63385.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/5874e9c3-6b01-46bd-ad8e-ae947dc63385/5874e9c3-6b01-46bd-ad8e-ae947dc63385.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>In patients with sepsis, coagulation pathways are frequently activated, promoting a prothrombotic state that may contribute to clot development and worsen disease severity and clinical outcomes. Coagulation abnormalities can range from mild...</itunes:subtitle><itunes:summary><![CDATA[In patients with sepsis, coagulation pathways are frequently activated, promoting a prothrombotic state that may contribute to clot development and worsen disease severity and clinical outcomes. Coagulation abnormalities can range from mild thrombocytopenia and subtle clotting disturbances to severe disseminated intravascular coagulation.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>287</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>24</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 23 - Heatwaves and Thrombosis</title><link>https://www.spreaker.com/episode/epi-23-heatwaves-and-thrombosis--72757707</link><description><![CDATA[As global temperatures continue to rise, heatwaves are becoming more frequent and intense, posing significant health risks. Prolonged exposure to high temperatures can alter normal physiological processes and increase the likelihood of thrombotic events, especially in vulnerable individuals.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/72757707</guid><pubDate>Fri, 28 Aug 2026 09:30:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/72757707/epi_23_heatwaves_and_thrombosis.mp3" length="3988937" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/d06c2632-0f77-4072-b14c-850fe8c8722f/d06c2632-0f77-4072-b14c-850fe8c8722f.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/d06c2632-0f77-4072-b14c-850fe8c8722f/d06c2632-0f77-4072-b14c-850fe8c8722f.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/d06c2632-0f77-4072-b14c-850fe8c8722f/d06c2632-0f77-4072-b14c-850fe8c8722f.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>As global temperatures continue to rise, heatwaves are becoming more frequent and intense, posing significant health risks. Prolonged exposure to high temperatures can alter normal physiological processes and increase the likelihood of thrombotic...</itunes:subtitle><itunes:summary><![CDATA[As global temperatures continue to rise, heatwaves are becoming more frequent and intense, posing significant health risks. Prolonged exposure to high temperatures can alter normal physiological processes and increase the likelihood of thrombotic events, especially in vulnerable individuals.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>248</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>23</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 22 - Portal Vein Thrombosis</title><link>https://www.spreaker.com/episode/epi-22-portal-vein-thrombosis--72498404</link><description><![CDATA[Traditionally, liver disease has been linked to an increased bleeding risk due to reduced production of coagulation factors. However, contemporary understanding recognizes a “rebalanced” hemostatic state, where both procoagulant and anticoagulant pathways are diminished. A common complication of advanced liver disease is portal vein thrombosis (PVT), a partial or complete obstruction of the portal vein caused by thrombus formation, which may extend to the superior mesenteric and splenic veins.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/72498404</guid><pubDate>Tue, 21 Jul 2026 09:35:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/72498404/epi_22_portal_vein_thrombosis.mp3" length="4375550" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d/7c89f15d-b466-4fbb-a02f-e5a8f94e7b7d.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Traditionally, liver disease has been linked to an increased bleeding risk due to reduced production of coagulation factors. However, contemporary understanding recognizes a “rebalanced” hemostatic state, where both procoagulant and anticoagulant...</itunes:subtitle><itunes:summary><![CDATA[Traditionally, liver disease has been linked to an increased bleeding risk due to reduced production of coagulation factors. However, contemporary understanding recognizes a “rebalanced” hemostatic state, where both procoagulant and anticoagulant pathways are diminished. A common complication of advanced liver disease is portal vein thrombosis (PVT), a partial or complete obstruction of the portal vein caused by thrombus formation, which may extend to the superior mesenteric and splenic veins.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>272</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>22</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 21 - Catastrophic APS</title><link>https://www.spreaker.com/episode/epi-21-catastrophic-aps--71987010</link><description><![CDATA[CAPS, also known as Asherson’s Syndrome, represents less than 1% of all APS cases but is widely recognized as its most severe clinical manifestation, with a mortality rate of 30–50% despite treatment. mortality rate of 30–50% despite treatment. Unlike classical APS, which usually involves isolated thrombosis or pregnancy morbidity, this form is characterized by rapidly progressive, simultaneous or sequential thromboses, frequently leading to multiorgan failure.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/71987010</guid><pubDate>Tue, 16 Jun 2026 09:40:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/71987010/epi_21_catastrophic_aps.mp3" length="4985352" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/917fe868-1db1-4379-a0c7-c1deaa59222a/917fe868-1db1-4379-a0c7-c1deaa59222a.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/917fe868-1db1-4379-a0c7-c1deaa59222a/917fe868-1db1-4379-a0c7-c1deaa59222a.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/917fe868-1db1-4379-a0c7-c1deaa59222a/917fe868-1db1-4379-a0c7-c1deaa59222a.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>CAPS, also known as Asherson’s Syndrome, represents less than 1% of all APS cases but is widely recognized as its most severe clinical manifestation, with a mortality rate of 30–50% despite treatment. mortality rate of 30–50% despite treatment. Unlike...</itunes:subtitle><itunes:summary><![CDATA[CAPS, also known as Asherson’s Syndrome, represents less than 1% of all APS cases but is widely recognized as its most severe clinical manifestation, with a mortality rate of 30–50% despite treatment. mortality rate of 30–50% despite treatment. Unlike classical APS, which usually involves isolated thrombosis or pregnancy morbidity, this form is characterized by rapidly progressive, simultaneous or sequential thromboses, frequently leading to multiorgan failure.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>310</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>21</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 20 -Post‑Thrombotic Syndrome</title><link>https://www.spreaker.com/episode/epi-20-post-thrombotic-syndrome--71234982</link><description><![CDATA[PTS is a chronic consequence of DVT, happening despite appropriate acute management. It affects 20% to 50% of patients within 2 years of DVT diagnosis, with severe forms in 5–10%. The condition usually involves the same limb affected by the original thrombosis, and symptoms may emerge shortly after the acute event or be delayed by months or even years.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/71234982</guid><pubDate>Tue, 19 May 2026 09:25:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/71234982/epi_20_post_thrombotic_syndrome.mp3" length="4612533" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>PTS is a chronic consequence of DVT, happening despite appropriate acute management. It affects 20% to 50% of patients within 2 years of DVT diagnosis, with severe forms in 5–10%. The condition usually involves the same limb affected by the original...</itunes:subtitle><itunes:summary><![CDATA[PTS is a chronic consequence of DVT, happening despite appropriate acute management. It affects 20% to 50% of patients within 2 years of DVT diagnosis, with severe forms in 5–10%. The condition usually involves the same limb affected by the original thrombosis, and symptoms may emerge shortly after the acute event or be delayed by months or even years.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>287</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>20</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 19 - Intracardiac Thrombosis</title><link>https://www.spreaker.com/episode/epi-19-intracardiac-thrombosis--70624044</link><description><![CDATA[Intracardiac thrombi form within the atria or ventricles of the heart and pose a substantial threat due to their potential to obstruct blood flow or embolize to distant organs. While less prevalent than venous thromboembolism, ICT remains a high‑risk cardiovascular emergency, with mortality rates that may reach or exceed 30–80%, depending on the patient’s clinical status and the location of the thrombus.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/70624044</guid><pubDate>Thu, 16 Apr 2026 09:25:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/70624044/epi_19_intracardiac_thrombosis.mp3" length="4098443" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Intracardiac thrombi form within the atria or ventricles of the heart and pose a substantial threat due to their potential to obstruct blood flow or embolize to distant organs. While less prevalent than venous thromboembolism, ICT remains a high‑risk...</itunes:subtitle><itunes:summary><![CDATA[Intracardiac thrombi form within the atria or ventricles of the heart and pose a substantial threat due to their potential to obstruct blood flow or embolize to distant organs. While less prevalent than venous thromboembolism, ICT remains a high‑risk cardiovascular emergency, with mortality rates that may reach or exceed 30–80%, depending on the patient’s clinical status and the location of the thrombus.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>254</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>19</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 18 - The Challenges of Post‑Op VTE</title><link>https://www.spreaker.com/episode/epi-18-the-challenges-of-post-op-vte--70077868</link><description><![CDATA[Surgical procedures create a uniquely pro‑thrombotic environment. Virchow’s triad—venous stasis, endothelial injury, and hypercoagulability—describes the foundation of thrombus formation, and all three elements are markedly amplified during and after surgery. Together, these factors significantly raise the risk of developing deep vein thrombosis (DVT), which can progress into life‑threatening pulmonary embolism (PE).<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/70077868</guid><pubDate>Thu, 12 Mar 2026 09:50:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/70077868/epi_18_the_challenges_of_post_op_vte.mp3" length="4505954" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Surgical procedures create a uniquely pro‑thrombotic environment. Virchow’s triad—venous stasis, endothelial injury, and hypercoagulability—describes the foundation of thrombus formation, and all three elements are markedly amplified during and after...</itunes:subtitle><itunes:summary><![CDATA[Surgical procedures create a uniquely pro‑thrombotic environment. Virchow’s triad—venous stasis, endothelial injury, and hypercoagulability—describes the foundation of thrombus formation, and all three elements are markedly amplified during and after surgery. Together, these factors significantly raise the risk of developing deep vein thrombosis (DVT), which can progress into life‑threatening pulmonary embolism (PE).<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>281</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>18</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 17 - Thrombosis in Myeloproliferative Neoplasms</title><link>https://www.spreaker.com/episode/epi-17-thrombosis-in-myeloproliferative-neoplasms--69517078</link><description><![CDATA[The classic Philadelphia-negative MPNs, which include Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are myeloproliferative disorders all characterized by clonal expansion of an abnormal hematopoietic stem/progenitor cell. This leads to excessive production of mature myeloid elements, such as an overabundance of red blood cells in PV or a marked increase in platelets in ET. Although biologically distinct, these disorders share a common predisposition to thrombosis<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/69517078</guid><pubDate>Tue, 17 Feb 2026 08:50:02 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/69517078/epi_17_thrombosis_in_myeloproliferative_neoplasms.mp3" length="4675228" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>The classic Philadelphia-negative MPNs, which include Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are myeloproliferative disorders all characterized by clonal expansion of an abnormal hematopoietic...</itunes:subtitle><itunes:summary><![CDATA[The classic Philadelphia-negative MPNs, which include Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are myeloproliferative disorders all characterized by clonal expansion of an abnormal hematopoietic stem/progenitor cell. This leads to excessive production of mature myeloid elements, such as an overabundance of red blood cells in PV or a marked increase in platelets in ET. Although biologically distinct, these disorders share a common predisposition to thrombosis<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>292</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>17</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 16 - Disseminated Intravascular Coagulation</title><link>https://www.spreaker.com/episode/epi-16-disseminated-intravascular-coagulation--69305617</link><description><![CDATA[Disseminated Intravascular Coagulation is a life-threatening intravascular disorder characterized by endothelial injury, systemic activation of coagulation, and dysregulated fibrinolysis, leading to microvascular thrombosis and consumption of platelets and clotting factors. <br />Importantly, Disseminated Intravascular Coagulation is not a primary disease but a complication of underlying conditions such as sepsis, trauma, malignancy, obstetric emergencies, or severe immune reactions. <br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/69305617</guid><pubDate>Thu, 15 Jan 2026 08:05:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/69305617/elevenlabs_2026_01_05t12_55_51_matilda_knowledgable_professional_pre_sp100_s50_sb75_se0_b_m2.mp3" length="4731652" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Disseminated Intravascular Coagulation is a life-threatening intravascular disorder characterized by endothelial injury, systemic activation of coagulation, and dysregulated fibrinolysis, leading to microvascular thrombosis and consumption of...</itunes:subtitle><itunes:summary><![CDATA[Disseminated Intravascular Coagulation is a life-threatening intravascular disorder characterized by endothelial injury, systemic activation of coagulation, and dysregulated fibrinolysis, leading to microvascular thrombosis and consumption of platelets and clotting factors. <br />Importantly, Disseminated Intravascular Coagulation is not a primary disease but a complication of underlying conditions such as sepsis, trauma, malignancy, obstetric emergencies, or severe immune reactions. <br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>295</itunes:duration><itunes:keywords>awareness,coagultion,disseminated,intravascular,thromboembolism,thrombosis,venous</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>16</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 15 - Cold-Induced Vascular Challenges</title><link>https://www.spreaker.com/episode/epi-15-cold-induced-vascular-challenges--68962703</link><description><![CDATA[Thrombosis, Cardiovascular Risks, and Raynaud’s Phenomenon <br />This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise the risk of thrombosis and vascular disorders, especially in individuals with pre-existing conditions. <br /><br />Winter is a critical period for vascular health. In fact, low temperatures trigger vasoconstriction, which, combined with increased platelet adhesion and reduced physical activity, heightens clot risk. The most strongly impacted pathology by cold-induced vasoconstriction is vascular disease. This deterioration occurs because constricted vessels raise blood pressure, slow circulation, limit tissue perfusion, and increase the likelihood of clot formation. <br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68962703</guid><pubDate>Fri, 09 Jan 2026 09:25:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68962703/epi_15_cold_induced_vascular_challenges.mp3" length="4104713" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Thrombosis, Cardiovascular Risks, and Raynaud’s Phenomenon 
This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise...</itunes:subtitle><itunes:summary><![CDATA[Thrombosis, Cardiovascular Risks, and Raynaud’s Phenomenon <br />This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise the risk of thrombosis and vascular disorders, especially in individuals with pre-existing conditions. <br /><br />Winter is a critical period for vascular health. In fact, low temperatures trigger vasoconstriction, which, combined with increased platelet adhesion and reduced physical activity, heightens clot risk. The most strongly impacted pathology by cold-induced vasoconstriction is vascular disease. This deterioration occurs because constricted vessels raise blood pressure, slow circulation, limit tissue perfusion, and increase the likelihood of clot formation. <br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>256</itunes:duration><itunes:keywords>awareness,cold,hemostasis,induced,raynaud,thrombosis</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>15</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 14 - Splanchnic Venous Thrombosis</title><link>https://www.spreaker.com/episode/epi-14-splanchnic-venous-thrombosis--68417941</link><description><![CDATA[In this episode, we highlight Splanchnic Venous Thrombosis, a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs. <br />Splanchnic Venous Thrombosis represents a heterogeneous group of disorders affecting the portal, mesenteric, splenic, and hepatic veins. While commonly linked to liver cirrhosis and malignancy, Splanchnic Venous Thrombosis can also occur in non-cirrhotic, non-neoplastic patients. Its clinical relevance stems from complications such as intestinal ischemia, portal hypertension, and potential underlying systemic disorders, including malignancies, nephrotic syndrome, thrombophilia, or inflammatory diseases.<br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68417941</guid><pubDate>Wed, 07 Jan 2026 09:10:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68417941/epi_14_splanchnic_venous_thrombosis.mp3" length="4250271" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>In this episode, we highlight Splanchnic Venous Thrombosis, a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs. 
Splanchnic Venous Thrombosis represents a heterogeneous group...</itunes:subtitle><itunes:summary><![CDATA[In this episode, we highlight Splanchnic Venous Thrombosis, a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs. <br />Splanchnic Venous Thrombosis represents a heterogeneous group of disorders affecting the portal, mesenteric, splenic, and hepatic veins. While commonly linked to liver cirrhosis and malignancy, Splanchnic Venous Thrombosis can also occur in non-cirrhotic, non-neoplastic patients. Its clinical relevance stems from complications such as intestinal ischemia, portal hypertension, and potential underlying systemic disorders, including malignancies, nephrotic syndrome, thrombophilia, or inflammatory diseases.<br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>266</itunes:duration><itunes:keywords>deep,dvt,embolism,hemostasis,pe,pulmonary,splanchnic,svt,thromboembolism,thrombosis,vein,venous,vte</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>14</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 13 - Travel Tips and Thrombosis</title><link>https://www.spreaker.com/episode/epi-13-travel-tips-and-thrombosis--68365052</link><description><![CDATA[Although the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help minimize the risk while traveling.<br />Listen for more information<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365052</guid><pubDate>Mon, 05 Jan 2026 09:35:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365052/epi_13_travel_tips_and_thrombosis.mp3" length="3603689" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Although the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help...</itunes:subtitle><itunes:summary><![CDATA[Although the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help minimize the risk while traveling.<br />Listen for more information<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>226</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,thrombosis,tips,travel,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>13</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 12 - Thrombotic Microangiopathies</title><link>https://www.spreaker.com/episode/epi-12-thrombotic-microangiopathies--68365047</link><description><![CDATA[This issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.<br />TMAs disrupt normal Hemostasis and often present with thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and organ dysfunction. Among these conditions, Thrombotic Thrombocytopenic Purpura (TTP) is one of the most studied and clinically significant subtypes due to its acute onset and high mortality if left untreated.<br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365047</guid><pubDate>Fri, 02 Jan 2026 09:35:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365047/epi_12_thrombotic_microangiopathies.mp3" length="4782640" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>This issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.
TMAs disrupt normal Hemostasis and often present with thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and organ...</itunes:subtitle><itunes:summary><![CDATA[This issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.<br />TMAs disrupt normal Hemostasis and often present with thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and organ dysfunction. Among these conditions, Thrombotic Thrombocytopenic Purpura (TTP) is one of the most studied and clinically significant subtypes due to its acute onset and high mortality if left untreated.<br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>298</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,microangiopathies,prevention,pulmonary,purpura,thrombocytopenic,thrombosis,thrombotic,tma,ttp,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>12</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 11 - Cerebral Venous Thrombosis</title><link>https://www.spreaker.com/episode/epi-11-cerebral-venous-thrombosis--68365057</link><description><![CDATA[In this new episode, we focus on Cerebral Venous Thrombosis (CVT), a rare yet serious condition involving blood clot formation in the brain’s venous system.<br />Unlike arterial strokes, which involve arterial occlusion, CVT impacts the cerebral venous outflow, including dural sinuses and cortical veins. This condition accounts for 0.5-3% of all strokes and is more prevalent in younger adults, particularly women under 50, and patients with underlying prothrombotic conditions.<br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365057</guid><pubDate>Mon, 29 Dec 2025 09:30:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365057/epi_11_cerebral_venous_thrombosis.mp3" length="4166680" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>In this new episode, we focus on Cerebral Venous Thrombosis (CVT), a rare yet serious condition involving blood clot formation in the brain’s venous system.
Unlike arterial strokes, which involve arterial occlusion, CVT impacts the cerebral venous...</itunes:subtitle><itunes:summary><![CDATA[In this new episode, we focus on Cerebral Venous Thrombosis (CVT), a rare yet serious condition involving blood clot formation in the brain’s venous system.<br />Unlike arterial strokes, which involve arterial occlusion, CVT impacts the cerebral venous outflow, including dural sinuses and cortical veins. This condition accounts for 0.5-3% of all strokes and is more prevalent in younger adults, particularly women under 50, and patients with underlying prothrombotic conditions.<br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>261</itunes:duration><itunes:keywords>awareness,cerebral,clot,coagulation,cvt,deep,dvt,embolism,hemostasis,pe,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>11</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 10 - Pulmonary Embolism and Chronic Obstructive Pulmonary Disease</title><link>https://www.spreaker.com/episode/epi-10-pulmonary-embolism-and-chronic-obstructive-pulmonary-disease--68365056</link><description><![CDATA[This episode explores the relationship between two complex medical conditions—Pulmonary Embolism (PE) and Chronic Obstructive Pulmonary Disease (COPD)—which often present similar symptoms, making accurate diagnosis particularly difficult.<br />PE and COPD are two critical respiratory conditions that frequently coexist, complicating diagnosis and treatment. PE involves the obstruction of pulmonary arteries by blood clots, usually originating from deep veins in the legs. COPD, a progressive lung disease, is characterized by airflow limitation and includes chronic bronchitis and emphysema.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365056</guid><pubDate>Mon, 22 Dec 2025 09:30:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365056/epi_10_pulmonary_embolism_and_chronic_obstructive_pulmonary_disease.mp3" length="4193429" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>This episode explores the relationship between two complex medical conditions—Pulmonary Embolism (PE) and Chronic Obstructive Pulmonary Disease (COPD)—which often present similar symptoms, making accurate diagnosis particularly difficult.
PE and COPD...</itunes:subtitle><itunes:summary><![CDATA[This episode explores the relationship between two complex medical conditions—Pulmonary Embolism (PE) and Chronic Obstructive Pulmonary Disease (COPD)—which often present similar symptoms, making accurate diagnosis particularly difficult.<br />PE and COPD are two critical respiratory conditions that frequently coexist, complicating diagnosis and treatment. PE involves the obstruction of pulmonary arteries by blood clots, usually originating from deep veins in the legs. COPD, a progressive lung disease, is characterized by airflow limitation and includes chronic bronchitis and emphysema.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>263</itunes:duration><itunes:keywords>awareness,clot,coagulation,copd,deep,dvt,embolism,hemostasis,pe,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>10</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 09 - Obstetric Antiphospholipid Syndrome</title><link>https://www.spreaker.com/episode/epi-09-obstetric-antiphospholipid-syndrome--68365050</link><description><![CDATA[This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.<br />Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365050</guid><pubDate>Fri, 19 Dec 2025 09:25:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365050/epi_09_obstetric_antiphospholipid_syndrome.mp3" length="4302098" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women...</itunes:subtitle><itunes:summary><![CDATA[This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.<br />Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>269</itunes:duration><itunes:keywords>antiphospholipid,aps,awareness,clot,coagulation,deep,embolism,hemostasis,obstetric,prevention,pulmonary,syndrome,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>9</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 08 - Catheter-related Thrombosis</title><link>https://www.spreaker.com/episode/epi-08-catheter-related-thrombosis--68365058</link><description><![CDATA[This episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is expected to rise further.<br /><br />Central venous catheters (CVCs) are indispensable in modern medicine, especially for patients needing long-term intravenous therapy, chemotherapy, hemodialysis, or parenteral nutrition. Despite their benefits, CVCs can lead to several complications, with CRT being one of the most significant.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365058</guid><pubDate>Wed, 17 Dec 2025 09:20:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365058/epi_08_catheter_related_thrombosis.mp3" length="4159574" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>This episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is...</itunes:subtitle><itunes:summary><![CDATA[This episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is expected to rise further.<br /><br />Central venous catheters (CVCs) are indispensable in modern medicine, especially for patients needing long-term intravenous therapy, chemotherapy, hemodialysis, or parenteral nutrition. Despite their benefits, CVCs can lead to several complications, with CRT being one of the most significant.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>260</itunes:duration><itunes:keywords>awareness,catheter,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>8</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 07 - Antiphospholipid Syndrome</title><link>https://www.spreaker.com/episode/epi-07-antiphospholipid-syndrome--68365054</link><description><![CDATA[This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.<br /><br />APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries, veins, or small vessels and/or spontaneous early miscarriages with maternal morbidity, caused by persistent antiphospholipid antibodies (aPL).<br /><br />The precise mechanisms by which aPLs lead to thrombosis are not fully understood. It is believed that these antibodies interfere with the normal function of phospholipids in the blood, essential for coagulation, leading to an increased risk of blood clot formation.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365054</guid><pubDate>Mon, 15 Dec 2025 16:20:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365054/epi_07_antiphospholipid_syndrome.mp3" length="4401573" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.

APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries,...</itunes:subtitle><itunes:summary><![CDATA[This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.<br /><br />APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries, veins, or small vessels and/or spontaneous early miscarriages with maternal morbidity, caused by persistent antiphospholipid antibodies (aPL).<br /><br />The precise mechanisms by which aPLs lead to thrombosis are not fully understood. It is believed that these antibodies interfere with the normal function of phospholipids in the blood, essential for coagulation, leading to an increased risk of blood clot formation.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>276</itunes:duration><itunes:keywords>antiphospholipid,awareness,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,syndrome,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>7</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 06 - May Thurner Syndrome</title><link>https://www.spreaker.com/episode/epi-06-may-thurner-syndrome--68365059</link><description><![CDATA[In this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is crucial, as DVT is often mistakenly seen as primarily affecting the elderly.<br />May-Thurner Syndrome (MTS), also known as iliac vein compression syndrome or Cockett's syndrome, occurs when the right iliac artery compresses the left iliac vein, restricting blood flow and causing it to pool in the leg. This compression disrupts normal blood flow, leading to various complications, including DVT. <br />While the prevalence of the disorder is unknown, this condition is found in 2–5% of patients undergoing evaluation for lower extremity venous disorders and often affects young women. <br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365059</guid><pubDate>Fri, 12 Dec 2025 09:15:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365059/epi_06_may_thurner_syndrome.mp3" length="3983986" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>In this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is crucial, as DVT is often mistakenly seen as primarily affecting the elderly....</itunes:subtitle><itunes:summary><![CDATA[In this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is crucial, as DVT is often mistakenly seen as primarily affecting the elderly.<br />May-Thurner Syndrome (MTS), also known as iliac vein compression syndrome or Cockett's syndrome, occurs when the right iliac artery compresses the left iliac vein, restricting blood flow and causing it to pool in the leg. This compression disrupts normal blood flow, leading to various complications, including DVT. <br />While the prevalence of the disorder is unknown, this condition is found in 2–5% of patients undergoing evaluation for lower extremity venous disorders and often affects young women. <br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>249</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,may,prevention,pulmonary,syndrome,thrombosis,thurner,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>6</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 05 - Upper Extremity Deep Vein Thrombosis</title><link>https://www.spreaker.com/episode/epi-05-upper-extremity-deep-vein-thrombosis--68365053</link><description><![CDATA[In this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. Despite being less prevalent than lower extremity DVT, UEDVT presents notable health risks and warrants significant attention.<br /><br />Etiology and Epidemiology<br /><br />UEDVT can arise from various factors. A common cause is the use of medical devices such as central venous catheters, pacemakers, or defibrillators, which can irritate or damage vein walls. Cancer and its treatments, particularly chemotherapy, can also elevate the risk. Additionally, repetitive arm movements, often seen in athletes, can result in Paget-Schroetter syndrome, a relatively rare type of UEDVT also known as “effort thrombosis”.<br />Nowadays, UEDVT accounts for 5% to 10% of all DVT cases, with incidence rates increasing annually. Most patients with UEDVT have a central line, with an incidence rate between 14% and 23%. Pulmonary embolism (PE) occurs in up to 6% of the cases.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365053</guid><pubDate>Wed, 10 Dec 2025 09:10:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365053/epi_05_upper_extremity_deep_vein_thrombosis.mp3" length="4261093" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>In this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. Despite being less prevalent than lower extremity DVT,...</itunes:subtitle><itunes:summary><![CDATA[In this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. Despite being less prevalent than lower extremity DVT, UEDVT presents notable health risks and warrants significant attention.<br /><br />Etiology and Epidemiology<br /><br />UEDVT can arise from various factors. A common cause is the use of medical devices such as central venous catheters, pacemakers, or defibrillators, which can irritate or damage vein walls. Cancer and its treatments, particularly chemotherapy, can also elevate the risk. Additionally, repetitive arm movements, often seen in athletes, can result in Paget-Schroetter syndrome, a relatively rare type of UEDVT also known as “effort thrombosis”.<br />Nowadays, UEDVT accounts for 5% to 10% of all DVT cases, with incidence rates increasing annually. Most patients with UEDVT have a central line, with an incidence rate between 14% and 23%. Pulmonary embolism (PE) occurs in up to 6% of the cases.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>267</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>5</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 04 - Understanding Thrombosis</title><link>https://www.spreaker.com/episode/epi-04-understanding-thrombosis--68365049</link><description><![CDATA[VTE is a leading cause of death and disability worldwide, affecting individuals of all ages, genders, and ethnicities. Often asymptomatic, misdiagnosed, and unrecognized at death, VTE poses a significant challenge for HCPs due to its insidiousness.<br /><br />Identifying and Managing Risk Factors<br /><br />Key VTE risk factors include immobility, surgery, specific medical conditions, lifestyle choices, and family history. Recognizing at-risk patients is the first step in preventing thrombosis. HCPs should educate each patient on preventing clot formation and prescribe mechanical prophylaxis and anticoagulants for High-risk individuals.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365049</guid><pubDate>Mon, 08 Dec 2025 09:10:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365049/epi_04_understanding_thrombosis.mp3" length="4774765" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>VTE is a leading cause of death and disability worldwide, affecting individuals of all ages, genders, and ethnicities. Often asymptomatic, misdiagnosed, and unrecognized at death, VTE poses a significant challenge for HCPs due to its insidiousness....</itunes:subtitle><itunes:summary><![CDATA[VTE is a leading cause of death and disability worldwide, affecting individuals of all ages, genders, and ethnicities. Often asymptomatic, misdiagnosed, and unrecognized at death, VTE poses a significant challenge for HCPs due to its insidiousness.<br /><br />Identifying and Managing Risk Factors<br /><br />Key VTE risk factors include immobility, surgery, specific medical conditions, lifestyle choices, and family history. Recognizing at-risk patients is the first step in preventing thrombosis. HCPs should educate each patient on preventing clot formation and prescribe mechanical prophylaxis and anticoagulants for High-risk individuals.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>299</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>4</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 03 - Unmasking Thrombophilia</title><link>https://www.spreaker.com/episode/epi-03-unmasking-thrombophilia--68365055</link><description><![CDATA[“Thrombophilia”, from the Greek words “trombo” (blood clot) and “philia” (affinity), indicates an increased tendency to form pathological intravascular thrombosis, which may develop spontaneously or at a young age. Screening is typically limited to high-risk individuals rather than the general population.<br />In the early 1980s, both Protein C and Protein S deficiencies were identified in the United States. These autosomal dominant conditions increase thrombosis risk 5- to 10-fold in heterozygotes, while homozygosity is often fatal without treatment. In 1994, Prof. Bertina and his team discovered FV Leiden. This mutation, converting arginine 506 to glutamine, makes FV resistant to inactivation by activated protein C, significantly raising VTE risk, and is observed in 1 to 5% of the general population, which represents 30 to 50% of all congenital thrombophilia cases.<br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365055</guid><pubDate>Fri, 05 Dec 2025 09:10:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365055/epi_03_unmasking_thrombophilia.mp3" length="4533185" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>“Thrombophilia”, from the Greek words “trombo” (blood clot) and “philia” (affinity), indicates an increased tendency to form pathological intravascular thrombosis, which may develop spontaneously or at a young age. Screening is typically limited to...</itunes:subtitle><itunes:summary><![CDATA[“Thrombophilia”, from the Greek words “trombo” (blood clot) and “philia” (affinity), indicates an increased tendency to form pathological intravascular thrombosis, which may develop spontaneously or at a young age. Screening is typically limited to high-risk individuals rather than the general population.<br />In the early 1980s, both Protein C and Protein S deficiencies were identified in the United States. These autosomal dominant conditions increase thrombosis risk 5- to 10-fold in heterozygotes, while homozygosity is often fatal without treatment. In 1994, Prof. Bertina and his team discovered FV Leiden. This mutation, converting arginine 506 to glutamine, makes FV resistant to inactivation by activated protein C, significantly raising VTE risk, and is observed in 1 to 5% of the general population, which represents 30 to 50% of all congenital thrombophilia cases.<br /><br /><br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>284</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,prevention,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>3</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 02 - History of Thrombosis</title><link>https://www.spreaker.com/episode/epi-02-history-of-thrombosis--68365048</link><description><![CDATA[The history of thrombosis is intertwined with the evolution of medicine, which was once closely linked to philosophy.  <br />Aristotle made significant observations on blood coagulation, attributing it to the presence of fibrous material in the blood. Galen, a prominent Roman physician whose theories influenced Western medicine for over a millennium, was the first to introduce the term “thrombosis”, derived from the Greek word for curdling. <br />Since then, thrombosis knowledge has evolved.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365048</guid><pubDate>Wed, 03 Dec 2025 09:00:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365048/epi_02_history_of_thrombosis.mp3" length="4027872" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>The history of thrombosis is intertwined with the evolution of medicine, which was once closely linked to philosophy.  
Aristotle made significant observations on blood coagulation, attributing it to the presence of fibrous material in the blood....</itunes:subtitle><itunes:summary><![CDATA[The history of thrombosis is intertwined with the evolution of medicine, which was once closely linked to philosophy.  <br />Aristotle made significant observations on blood coagulation, attributing it to the presence of fibrous material in the blood. Galen, a prominent Roman physician whose theories influenced Western medicine for over a millennium, was the first to introduce the term “thrombosis”, derived from the Greek word for curdling. <br />Since then, thrombosis knowledge has evolved.<br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>252</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>2</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Epi 01 - Thrombosis - A Silent Killer</title><link>https://www.spreaker.com/episode/epi-01-thrombosis-a-silent-killer--68365051</link><description><![CDATA[Thrombosis: A Silent Killer<br /><br />Thrombosis, the formation of a blood clot within a blood vessel, is a serious health condition that often goes unnoticed until it's too late. This silent killer can lead to devastating complications, including heart attacks, strokes, and pulmonary embolisms. <br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/68365051</guid><pubDate>Fri, 31 Oct 2025 14:59:06 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/68365051/epi_01_thrombosis_a_silent_killer.mp3" length="3894961" type="audio/mpeg"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>EEMEA</itunes:author><itunes:subtitle>Thrombosis: A Silent Killer

Thrombosis, the formation of a blood clot within a blood vessel, is a serious health condition that often goes unnoticed until it's too late. This silent killer can lead to devastating complications, including heart...</itunes:subtitle><itunes:summary><![CDATA[Thrombosis: A Silent Killer<br /><br />Thrombosis, the formation of a blood clot within a blood vessel, is a serious health condition that often goes unnoticed until it's too late. This silent killer can lead to devastating complications, including heart attacks, strokes, and pulmonary embolisms. <br /><br /><br /><br /><br /><br /><br />Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.<br />This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. <br />We hope you join this effort!<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>244</itunes:duration><itunes:keywords>awareness,clot,coagulation,deep,embolism,hemostasis,pulmonary,thrombosis,vein</itunes:keywords><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/fef6a453dfd7011ea46fe5e97245dcb8.jpg"/><itunes:episode>1</itunes:episode><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
